KC

Krishna Chaitanya Nalamotu

Director Director DIN 03338915
DIN 03338915 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value •••• Premium profile

About Krishna Chaitanya Nalamotu

Data last updated:

Krishna Chaitanya Nalamotu was a Director at Thexa Pharma Private Limited (2010–2012) and Director at Aradhan Chemtech Private Limited (2011–2019). The companies operate in Pharma.

DIN 03338915
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Thexa Pharma Private Limited U24232TG2007PTC056165
Director27 Dec 20102007₹9.03 Cr (FY 2018)Active
Aradhan Chemtech Private Limited U24100TG2010PTC068967
Director16 Apr 20112010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Thexa Pharma Private Limited
Aradhan Chemtech Private Limited
Premium access

Shareholding and investment profile for Krishna Chaitanya Nalamotu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Chaitanya Nalamotu

Krishna Chaitanya Nalamotu was first appointed on 27 Dec 2010 as Director at Thexa Pharma Private Limited. The most recent appointment on record is 16 Apr 2011 at Aradhan Chemtech Private Limited.

Krishna Chaitanya Nalamotu held 2 earlier board appointments: Thexa Pharma Private Limited (Director, 27 Dec 2010 to 17 Jun 2012); Aradhan Chemtech Private Limited (Director, 16 Apr 2011 to 20 Apr 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available